CytoDyn Inc. Depreciation
CytoDyn Inc. (CYDY) reported Depreciation of $5.00 thousand for the 3-month period ending 2025-02-28, per its 10-Q filed 2025-04-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-04-14
- CytoDyn Inc. depreciation for the quarter ending 2025-02-28 was $5.00K, a 28.57% decline year-over-year.
- CytoDyn Inc. depreciation for the quarter ending 2024-11-30 was $4.00K, a 50.00% decline year-over-year.
- CytoDyn Inc. depreciation for the quarter ending 2024-08-31 was $5.00K, a 50.00% decline year-over-year.
- CytoDyn Inc. depreciation for the quarter ending 2024-05-31 was $4.00K.
- CytoDyn Inc. depreciation for fiscal 2024 was $29.00K, a 32.56% decline from fiscal 2023.
- CytoDyn Inc. depreciation for fiscal 2023 was $43.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-02-28 | $5.00K 10-Q · filed 2025-04-14 | $9.00K derived: sum of 2 quarters · filed 2025-04-14 | $14.00K 10-Q · filed 2025-04-14 | $18.00K derived: sum of 4 quarters · filed 2025-04-14 |
| 2024-11-30 | $4.00K 10-Q · filed 2025-01-14 | $9.00K 10-Q · filed 2025-01-14 | $13.00K derived: sum of 3 quarters · filed 2025-01-14 | $20.00K derived: sum of 4 quarters · filed 2025-04-14 |
| 2024-08-31 | $5.00K 10-Q · filed 2024-10-15 | $9.00K derived: sum of 2 quarters · filed 2024-10-15 | $16.00K derived: sum of 3 quarters · filed 2025-04-14 | $24.00K derived: sum of 4 quarters · filed 2025-04-14 |
| 2024-05-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-15 | $11.00K derived: sum of 2 quarters · filed 2025-04-14 | $19.00K derived: sum of 3 quarters · filed 2025-04-14 | $29.00K 10-K · filed 2024-08-15 |
| 2024-02-29 | $7.00K 10-Q · filed 2025-04-14 | $15.00K derived: sum of 2 quarters · filed 2025-04-14 | $25.00K 10-Q · filed 2025-04-14 | |
| 2023-11-30 | $8.00K 10-Q · filed 2025-01-14 | $18.00K 10-Q · filed 2025-01-14 | ||
| 2023-08-31 | $10.00K 10-Q · filed 2024-10-15 | |||
| 2023-05-31 | $43.00K 10-K · filed 2024-08-15 |